Moving the goal posts: PARASHIFT proton magnetic resonance imaging
Lead Research Organisation:
Newcastle University
Department Name: Institute of Cellular Medicine
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
Publications
Senanayake PK
(2017)
A new paramagnetically shifted imaging probe for MRI.
in Magnetic resonance in medicine
Moore U
(2019)
Assessment of disease progression in dysferlinopathy: A 1-year cohort study.
in Neurology
Onofrj M
(2018)
GABA and hallucinations in Parkinson disease Who is that sitting on my chair?
in Neurology
Firbank M
(2018)
Reduced occipital GABA in Parkinson disease with visual hallucinations
in Neurology
Harris E
(2016)
The Clinical Outcome Study for dysferlinopathy: An international multicenter study.
in Neurology. Genetics
| Description | The funding covers development of a new type of MRI contrast agent for molecular imaging. This is under development. |
| Exploitation Route | The work is in the early phases of development but with promising findings. We anticipate there being opportunities to link the contrast agents to proteins or antibodies to develop targetted MRI contrast agents in the future once the work is completed, protected and published. |
| Sectors | Chemicals Healthcare |
| Description | Project is in the earliest phases of development and findings from this work are not yet published. |